NIH study traces molecular link from gene to late-onset retinal degeneration
Clinical trial planning underway to test the widely used diabetes drug metformin as a preventive treatment for the blinding eye disease. (Source: National Institutes of Health (NIH) News Releases)
Source: National Institutes of Health (NIH) News Releases - December 8, 2021 Category: American Health Source Type: news
Semaglutide + metformin not cost effective vs empagliflozin + metformin for T2DM in Denmark
(Source: PharmacoEconomics and Outcomes News)
Source: PharmacoEconomics and Outcomes News - December 1, 2021 Category: Drugs & Pharmacology Source Type: news
T2DM and Markers of Cutaneous Melanoma Aggressiveness T2DM and Markers of Cutaneous Melanoma Aggressiveness
This study investigated a possible relationship between type 2 diabetes mellitus and an increased incidence and/or aggressiveness of melanoma, with or without metformin therapy.The British Journal of Dermatology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - November 10, 2021 Category: Consumer Health News Tags: Dermatology Journal Article Source Type: news
Maraviroc, Metformin Fail to Control NAFLD in People With HIV Maraviroc, Metformin Fail to Control NAFLD in People With HIV
In some cases, liver fat actually increased in the first randomized controlled trial to study the HIV drug maraviroc in combination with metformin for nonalcoholic fatty liver disease in people with HIV.Medscape Medical News (Source: Medscape Gastroenterology Headlines)
Source: Medscape Gastroenterology Headlines - November 5, 2021 Category: Gastroenterology Tags: HIV/AIDS News Source Type: news
Glenmark launches unique fixed dose combination drug for diabetes
The Mumbai based drug firm said it has introduced fixed dose combination (FDC) of its novel, patent protected Sodium Glucose Co-Transporter Inhibitor (SGLT2i) - Remogliflozin Etabonate and another widely used DPP4 inhibitor (Dipeptidyl Peptidase 4 inhibitor) - Vildagliptin, with Metformin. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - October 26, 2021 Category: Pharmaceuticals Source Type: news
Drugs for treating diabetes, obesity & ageing can potentially be used to treat Covid: Researchers
The scientists believe that natural compounds such as curcumin and resveratrol, among others, and existing drugs such as metformin and Rapamyci have potential to get tested extensively for the treatment of COVID-19 and post-coronavirus syndrome. (Source: The Economic Times)
Source: The Economic Times - October 11, 2021 Category: Consumer Health News Source Type: news
Effect of Aloe vera as a local drug delivery agent in the management of periodontal diseases: A systematic review and meta-analysis
Conclusion: Results from our meta-analyses confirmed the beneficial effects of A. vera in improving the periodontal parameters and hence may be considered as a safe alternative drug delivery agent for the management of periodontal diseases in future. (Source: Dental Technology Blog)
Source: Dental Technology Blog - September 10, 2021 Category: Dentistry Source Type: news
Continuous veno-venous hemodiafiltration in metformin-associated lactic acidosis caused by a suicide attempt: a report of two cases - Tuncali B, Temizkan K ırkayak AG, Zeyneloğlu P.
Lactic acidosis is the most important and life-threatening side effect of metformin that is widely used in the treatment of type 2 diabetes mellitus. In this case report, two cases who were treated in our intensive care unit for lactic acidosis due to high... (Source: SafetyLit)
Source: SafetyLit - September 6, 2021 Category: International Medicine & Public Health Tags: Economics of Injury and Safety, PTSD, Injury Outcomes Source Type: news
Metformin Disappoints in Two Phase 2 Lung Cancer Trials Metformin Disappoints in Two Phase 2 Lung Cancer Trials
Although well tolerated, metformin did not improve survival when given alongside chemoradiotherapy to patients with locally advanced non-small cell lung cancer (NSCLC).Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - September 3, 2021 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news
Health chiefs recall batch of diabetes medicine Metformin after cancer-causing chemical find
British pharmacies stocking the affected medicine - an oral solution known as metformin - were told to pull it after finding it contained nitrosodimethylamine. (Source: the Mail online | Health)
Source: the Mail online | Health - August 25, 2021 Category: Consumer Health News Source Type: news
Class 2 Medicines Recall: Rosemont Pharmaceuticals Limited, Metformin Hydrochloride 500mg/5ml Oral Solution
Rosemont Pharmaceuticals Limited is recalling all unexpired stock of Metformin Hydrochloride 500mg/5ml Oral Solutionfrom pharmacies and wholesalers as a precautionary measure due to the identification (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - August 25, 2021 Category: Drugs & Pharmacology Source Type: news
Half Abandon Metformin Within a Year of Diabetes Diagnosis Half Abandon Metformin Within a Year of Diabetes Diagnosis
Multiple factors blamed for the drop-off, while improved communication, follow-up, and medication adjustment advised as remedies.Medscape Medical News (Source: Medscape FamilyMedicine Headlines)
Source: Medscape FamilyMedicine Headlines - August 3, 2021 Category: Primary Care Tags: Diabetes & Endocrinology News Source Type: news
